MRK : NYSE
Industry: Pharmaceuticals

Balance Sheet
2008
12/31/08
2007
12/31/07
2006
12/31/06
2005
12/31/05
Cash4,3685,3365,9159,585
Short Term Investments1,1182,8952,7986,052
ASSETS
Cash & Short Term Investments5,4868,2318,71315,638
Receivables - Net3,7793,6363,3152,927
Raw Materials1,8511,4981,3661,258
Finished Goods433383404400
Inventories - Total2,2831,8811,7691,658
Prepaid Expenses--468255164
Other Current Assets7,7568301,178662
CURRENT ASSETS - TOTAL19,30515,04515,23021,049
Land386406409433
Buildings9,76710,0489,7469,480
Machinery & Equipment13,10413,55413,17212,785
Property, Plant and Equipment - Gross24,12824,80324,21023,713
Accumulated Depreciation(12,129)(12,457)(11,015)(9,315)
Property, Plant and Equipment - Net12,00012,34613,19414,398
Long Term Receivables623--00
Investments in Associated Companies1,4003,9003,5003,000
Other Investments6,4917,1597,7881,108
Other Tangible Assets3,7464,9082,2983,617
Total Intangible Other Assets - Net1,9642,1682,3761,604
Other Assets - Total7,3769,9004,8575,290
TOTAL ASSETS45,52945,52744,38644,777
LIABILITIES
Accounts Payable618624497471
Short Term Debt & Current Portion of Long Term Debt2,2971,8241,2852,972
Income Taxes Payable1,4264443,4613,649
Dividends Payable804831827830
Other Current Liabilities9,1748,5356,6535,381
CURRENT LIABILITIES - TOTAL14,31912,25812,72313,303
Long Term Debt3,9433,9165,5515,126
Deferred Taxes - Credit3123968531,270
Deferred Taxes - Debit1,6672,82418469
DEFERRED TAXES(1,354)(2,428)6691,201
Other Liabilities7,45411,1905,4784,823
TOTAL LIABILITIES24,36224,93624,42024,454
EQUITY
Non-Equity Reserves0000
Minority Interest2,4092,4072,4062,407
Preferred Stock0000
Common Stock30303030
Capital Surplus8,3198,0157,1666,900
Other Appropriated Reserves(2,755)(993)(1,233)(23)
Retained Earnings43,69939,14139,09537,919
Unrealized Foreign Exchange Gain/Loss1386319(300)K
Unrealized Gain/Loss on Marketable Securities631045075
Treasury Stock(30,735)(28,175)(27,567)(26,984)
COMMON EQUITY18,75818,18517,56017,917
TOTAL LIABILITIES & SHAREHOLDERS’ EQUITY45,52945,52744,38644,777
SHARE INFORMATION
Common Shares Outstanding2,1082,1732,1682,182
2009 Q3
9/30/09
2009 Q2
6/30/09
2009 Q1
3/31/09
2008 Q4
12/31/08
2008 Q3
9/30/08
Cash------4,368--
ASSETS
Cash & Short Term Investments22,25616,93212,5825,4866,841
Receivables - Net3,8043,6633,5703,7793,643
Inventories - Total2,0962,1552,1282,2832,228
Prepaid Expenses----------
Other Current Assets1,5126,4837,9067,7566,706
CURRENT ASSETS - TOTAL29,66929,23426,18519,30519,418
Property, Plant and Equipment - Gross23,97224,12524,27924,12823,972
Accumulated Depreciation(12,358)(12,414)(12,453)(12,129)(11,869)
Property, Plant and Equipment - Net11,61411,71111,82612,00012,103
Investments in Associated Companies0----1,400--
Total Intangible Other Assets - Net1,9952,0202,0531,9641,997
Other Assets - Total7,4578,4628,53214,49117,024
TOTAL ASSETS48,73949,40746,54345,52948,546
LIABILITIES
Accounts Payable568527622618475
Short Term Debt & Current Portion of Long Term Debt8672,5022,7992,2972,994
Income Taxes Payable4752734801,426879
Other Current Liabilities6,1168,2069,5149,97810,080
CURRENT LIABILITIES - TOTAL8,02611,50713,41614,31914,428
Long Term Debt8,2058,1813,9393,9433,939
Deferred Taxes - Credit7,1426,9827,1873128,168
Deferred Taxes - Debit------1,667--
DEFERRED TAXES7,1426,9827,187(1,354)8,168
Other Liabilities18007,4540
TOTAL LIABILITIES23,39026,67024,54224,36226,535
EQUITY
Non-Equity Reserves00000
Minority Interest2,4422,4122,4392,4092,440
Preferred Stock00000
Common Stock3030303030
Capital Surplus8,5428,4668,3878,3198,269
Retained Earnings47,69345,07344,32043,69942,857
Unrealized Foreign Exchange Gain/Loss------138--
Unrealized Gain/Loss on Marketable Securities------63--
Treasury Stock(30,683)(30,694)(30,701)(30,735)(30,552)
COMMON EQUITY22,90720,32419,56318,75819,571
TOTAL LIABILITIES & SHAREHOLDERS’ EQUITY48,73949,40746,54345,52948,546
SHARE INFORMATION
Common Shares Outstanding2,1092,1092,1092,1082,114
() = Negative Values
Values are displayed in Millions except for earnings per share and where noted